| Balance sheet (USD) | FY 2025 ended Dec 31, 2025 | FY 2024 ended Dec 31, 2024 | FY 2023 ended Dec 31, 2023 | FY 2022 ended Dec 31, 2022 | FY 2021 ended Dec 31, 2021 | FY 2020 ended Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 5.23B | 5.52B | 12.81B | 9.20B | 9.75B | 8.45B |
| Short-term investments | 28.00M | 31.00M | 2.00M | 28.00M | 84.00M | 30.00M |
| Receivables | 12.59B | 10.92B | 11.15B | 11.25B | 9.98B | 8.82B |
| Inventory | 4.95B | 4.18B | 4.10B | 3.58B | 3.13B | 3.31B |
| Total current assets | 29.06B | 25.58B | 33.00B | 28.46B | 27.93B | 24.17B |
| Property, plant and equipment | 5.63B | 5.13B | 4.99B | 4.93B | 5.11B | 5.25B |
| Goodwill and intangibles | 88.28B | 95.02B | 87.90B | 99.59B | 108.33B | 116.00B |
| Total assets | 133.96B | 135.16B | 134.71B | 138.81B | 146.53B | 150.56B |
| Accounts payable | 3.59B | 2.94B | 3.69B | 2.93B | 2.88B | 2.28B |
| Total current liabilities | 43.29B | 38.75B | 37.84B | 29.54B | 35.19B | 28.66B |
| Long-term debt | 58.94B | 60.34B | 52.19B | 59.13B | 64.19B | 77.55B |
| Total liabilities | 137.23B | 131.84B | 124.35B | 121.55B | 131.12B | 137.49B |
| Retained earnings | -15.49B | -7.90B | -1.00B | 4.78B | 3.13B | 1.05B |
| Shareholders' equity | -3.27B | 3.33B | 10.36B | 17.25B | 15.41B | 13.08B |
| Total debt | 61.44B | 60.34B | 52.19B | 59.14B | 64.20B | 77.59B |
| Net debt | 56.21B | 54.82B | 39.38B | 49.94B | 54.46B | 69.14B |
From AbbVie's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.